US Broker Ratings

Organon & Co. (OGN) Stock Analysis: Exploring a Compelling 27% Potential Upside in the Healthcare Sector

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, commands attention from investors with its expansive portfolio of health solutions, ranging from women’s health products to biosimilars..

CONMED Corporation (CNMD) Stock Analysis: Navigating a 33.57% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, has recently caught the attention of investors. With a market cap of $1.42 billion and..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 38.67% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the U.S. healthcare sector, offers a compelling investment opportunity with a potential upside of 38.67%, according to recent analyst ratings...

Evotec SE (EVO) Stock Analysis: Unpacking a Potential 69.89% Upside for Investors

Evotec SE (EVO), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, has captured the attention of investors with its potential upside of nearly 69.89%. This..

BGM Group Ltd. (BGM): A Healthcare Contender Amidst Market Challenges – Investor Outlook

BGM Group Ltd. (BGM), a player in China’s healthcare sector, is carving out its niche in the specialty and generic drug manufacturing industry. Despite operating in a dynamic and demanding..

National HealthCare Corporation (NHC) Stock Analysis: Unpacking the Growth Potential in Healthcare Facilities

National HealthCare Corporation (NHC) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Murfreesboro, Tennessee, NHC has crafted a robust portfolio..

Brookdale Senior Living Inc. (BKD): Navigating Challenges with a 4.80% Revenue Growth in Healthcare

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.98 billion, the..

Supernus Pharmaceuticals (SUPN): Investor Outlook on a Rising Biopharma Star with Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is carving out a notable niche within the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of $2.67..

Recursion Pharmaceuticals (RXRX) Stock Analysis: A Biotech Gem with 31.70% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery. Operating as a clinical-stage biotech company, Recursion is leveraging cutting-edge technology..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a Potential 129.55% Upside

For investors with a keen eye on the biotechnology sector, Edgewise Therapeutics, Inc. (NASDAQ: EWTX) presents a compelling opportunity with its substantial upside potential. The company, which focuses on pioneering..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Highlights Robust Revenue Growth and Analyst Confidence

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company based in Foster City, California, has been capturing the attention of investors with its innovative approach to treating rare and orphan diseases...

Artivion, Inc. (AORT) Stock Analysis: Navigating a 5.95% Potential Upside in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the medical devices industry, is drawing significant interest from investors eager to tap into its promising growth potential. With a market capitalization of..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unpacking a Potential 712% Upside in the Biotech Arena

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning force in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and the potential for significant stock appreciation. Based in..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with Nearly 49% Upside

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a dynamic player in the biotechnology sector, is capturing the attention of investors with its promising therapeutic developments and substantial growth potential. Headquartered in..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Potential 31.89% Upside in Biotechnology

Investors with an eye on the biotechnology sector may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) a compelling opportunity, especially with analysts forecasting a potential upside of 31.89%. This clinical-stage biopharmaceutical..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 296.89% Potential Upside Captures Investor Attention

ImmunityBio, Inc. (NASDAQ: IBRX) is making waves in the biotechnology sector with a remarkable potential upside of nearly 297%, according to current analyst ratings. This San Diego-based biotech firm is..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 49.75% Potential Upside in Biotech

For investors with a keen interest in the biotechnology sector, Travere Therapeutics, Inc. (NASDAQ: TVTX) presents an intriguing opportunity. This San Diego-based biopharmaceutical company operates in the highly specialized arena..

Mesoblast Limited (MESO): Investor Outlook Highlights 68.54% Potential Upside

Mesoblast Limited (NASDAQ: MESO), a key player in the biotechnology sector, is currently capturing investor attention with a compelling potential upside of 68.54%, based on its current stock price and..

Azenta, Inc. (AZTA) Investor Outlook: Navigating the Healthcare Sector with a 17% Upside Potential

Azenta, Inc. (AZTA), a key player in the healthcare sector, focuses on providing innovative sample exploration and management solutions for the life sciences industry. Based in Burlington, Massachusetts, Azenta operates..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 116.94% Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of the biotechnology sector, focusing on the discovery and development of therapeutics for neurodegenerative and lysosomal storage diseases. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds